Invivyd, Inc. Files 8-K Report

Ticker: IVVD · Form: 8-K · Filed: Sep 6, 2024 · CIK: 1832038

Invivyd, INC. 8-K Filing Summary
FieldDetail
CompanyInvivyd, INC. (IVVD)
Form Type8-K
Filed DateSep 6, 2024
Risk Levellow
Pages1
Reading Time2 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 8-k, routine-report

TL;DR

Invivyd filed its 8-K. Nothing major, just routine SEC stuff.

AI Summary

Invivyd, Inc. filed an 8-K on September 6, 2024, to report other events and financial statements. The company, formerly known as Adagio Therapeutics, Inc., is incorporated in Delaware and headquartered in Waltham, MA. This filing does not contain specific financial figures or transactional details beyond its routine reporting nature.

Why It Matters

This 8-K filing serves as a routine update for Invivyd, Inc. and its shareholders, indicating the submission of required financial and event information to the SEC.

Risk Assessment

Risk Level: low — The filing is a standard 8-K report and does not disclose any new material risks or significant negative events.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Invivyd, Inc.?

The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of September 6, 2024.

When was Invivyd, Inc. previously known by another name?

Invivyd, Inc. was formerly known as Adagio Therapeutics, Inc., with a date of name change not specified in this excerpt but implied by the filing.

Where are Invivyd, Inc.'s principal executive offices located?

Invivyd, Inc.'s principal executive offices are located at 1601 Trapelo Road, Suite 178, Waltham, MA 02451.

What is the state of incorporation for Invivyd, Inc.?

Invivyd, Inc. is incorporated in Delaware.

What is the filing date for this 8-K report?

The filing date for this 8-K report is September 6, 2024.

Filing Stats: 419 words · 2 min read · ~1 pages · Grade level 10.3 · Accepted 2024-09-06 09:05:57

Key Financial Figures

Filing Documents

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Corporate Presentation, dated September 6, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INVIVYD, INC. Date: September 6, 2024 By: /s/ Jill Andersen Jill Andersen Chief Legal Officer and Corporate Secretary

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing